Where the Rule Came From
Section 280E entered the tax code after a court allowed a narcotics dealer to deduct ordinary business costs on a federal return. Congress closed that door by barring deductions and credits for any trade or business trafficking in a substance listed on Schedule I or II of the Controlled Substances Act.
Cannabis has not moved off Schedule I as a matter of federal law, so a New Mexico license issued under the Cannabis Regulation Act carries no federal insulation. Rescheduling proposals are worth watching, but an operator should build a plan around the law as it stands, not as it might eventually become.
The One Door That Stays Open
Congress cannot legislate away the concept of gross income, and gross income from selling goods is receipts minus the cost of those goods. Cost of goods sold is a computation that happens before 280E ever applies, which is why it remains available to plant-touching businesses everywhere, including New Mexico.
Everything about lawful cannabis tax planning reduces to one question: what belongs in cost of goods sold under the applicable inventory rules, and can the taxpayer prove it with contemporaneous records?
Retailers Versus Producers
A retail dispensary computes cost of goods sold narrowly — invoice cost plus freight and other direct acquisition charges. A cultivator or manufacturer computes it far more broadly, capitalizing direct materials, direct labor, and a wide band of indirect production costs.
The result is that two operators with identical total spending can land on very different federal tax bills depending purely on license type, which is why vertically integrated New Mexico operators need functional separation built into their books, not just their org charts.
- Retailer: invoice price, inbound freight, direct costs of acquisition
- Producer: direct materials, direct labor, allocable indirect production costs
- Neither: marketing, delivery to the customer, general administrative overhead
The Real-World Bite
Because the federal tax base is gross profit rather than net income, a New Mexico dispensary running thin margins can post a federal tax liability in the same year it loses money on a cash basis. Effective federal rates well north of statutory corporate or individual rates are the norm in this industry.
The countermeasures are structural, not clever: capture every dollar of legitimate inventoriable cost, treat non-inventoriable spending as expensive because it is funded with after-tax dollars, choose an entity that doesn't dump the liability onto owners personally, and reserve cash for the obligation throughout the year rather than at filing time.
Gross Receipts Tax Runs on a Separate Track
New Mexico's Gross Receipts Tax and the state's Cannabis Excise Tax are governed by state statute and administered by the Taxation and Revenue Department — they are entirely separate from 280E and from the federal return. Medical cannabis sold to patients enrolled in the state's medical program is exempt from both GRT and the excise tax, which means a single business selling to both adult-use and medical customers has to segregate those transactions cleanly in its books.
That segregation isn't optional bookkeeping hygiene — it directly changes what the business owes each filing period and what the federal 280E computation looks like as well.
Positions the IRS Has Successfully Challenged
Federal courts have rejected attempts to relabel selling costs as inventory costs, to run a paper-only management entity with no operational substance as a separate business, and to apply producer-level capitalization to what is, in substance, a pure retail storefront.
The consistent lesson: documentation and operational reality carry the day, and a structure that only exists on an organizational chart will not hold up.
